A federal judge has temporarily banned Colorado from capping the price of Amgen's arthritis drug Enbrel while a lawsuit challenging the state drug affordability board's action plays

A widening gap between retirement expectations versus preparedness is fundamentally reshaping planning and accelerating demand for solutions that can deliver predictable income, such as annuity products.

The complaint adds to a growing wave of ERISA litigation testing employers' ongoing duty to monitor and replace underperforming 401(k) investments.

An activist investor has asked the firm to stop buying back its own stock and start buying more companies.